Literature DB >> 28478273

Nobiletin improves propofol-induced neuroprotection via regulating Akt/mTOR and TLR 4/NF-κB signaling in ischemic brain injury in rats.

Yuzhen Zheng1,2, Jinmei Bu1,2, Liang Yu1, Jun Chen1, Haigen Liu1,2,3.   

Abstract

BACKGROUND: Stroke is regarded as one of the main health concerns globally, presenting with high mortality and morbidity rates. Cerebral ischemic damage and infarction are critically associated with stroke. Various mechanisms related to inflammation, oxidative stress and excitotoxicity are found to be involved in ischemic damage. Very short time period for treatment has necessitated in development of more effective neuroprotective agents. Study aimed in investigated the effects of nobiletin on experimentally induced ischemic brain injury and also to assess whether nobiletin potentiated the neuroprotective effects of propofol.
METHODS: Male Sprague-Dawley rats were subjected to ischemia/reperfusion (I/R) injury. Induction of cerebral infarction and I/R was done by middle cerebral artery occlusion (MCAO). Nobiletin (100 or 200mg/kg b.wt.) was intragastrically administered to rats for 9 days before ischemia induction and on the day of induction nobiletin was administered an hour prior. Separate group of rats were post-conditioned with propofol (50mg/kg/h; i.v.) for 30min following 24h of reperfusion.
RESULTS: Propofol post-conditioning either with or without administration of nobiletin prior I/R injury attenuated pulmonary edema, neuronal apoptosis and reduced cerebral infarct volume. Overproduction of pro-inflammatory cytokines (TNF-α, IL-1β and IL-6) and nitric oxide following I/R were reduced. Propofol either alone or with prior nobiletin treatment had down-regulated TLR4 and TLR4-mediated NF-κB signaling and caused activation of Akt/mTOR cascade.
CONCLUSION: Propofol post-conditioning either with nobiletin prior I/R injury was found to be more effective than propofol alone, suggesting the positive effects of nobiletin on propofol-mediated anti-inflammatory and neuroprotective effects.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Ischemic brain injury; Nobiletin; Nuclear factor-κB signaling; Protein kinase B (Akt); Toll-like receptor 4 (TLR4)

Mesh:

Substances:

Year:  2017        PMID: 28478273     DOI: 10.1016/j.biopha.2017.04.048

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  15 in total

1.  Nobiletin alleviates cerebral ischemic-reperfusion injury via MAPK signaling pathway.

Authors:  Tao Wang; Feng Wang; Lu Yu; Zaiwang Li
Journal:  Am J Transl Res       Date:  2019-09-15       Impact factor: 4.060

Review 2.  Nobiletin as an inducer of programmed cell death in cancer: a review.

Authors:  Jun Huang; Zaoshang Chang; Quzhe Lu; Xuedong Chen; Masoud Najafi
Journal:  Apoptosis       Date:  2022-03-21       Impact factor: 4.677

3.  Xueshuantong injection (lyophilized) combined with salvianolate lyophilized injection protects against focal cerebral ischemia/reperfusion injury in rats through attenuation of oxidative stress.

Authors:  Fu-Jiang Wang; Shao-Xia Wang; Li-Juan Chai; Yue Zhang; Hong Guo; Li-Min Hu
Journal:  Acta Pharmacol Sin       Date:  2017-10-12       Impact factor: 6.150

Review 4.  Neuroprotective Phytochemicals in Experimental Ischemic Stroke: Mechanisms and Potential Clinical Applications.

Authors:  Hui Xu; Emily Wang; Feng Chen; Jianbo Xiao; Mingfu Wang
Journal:  Oxid Med Cell Longev       Date:  2021-04-28       Impact factor: 6.543

5.  Meisoindigo Protects Against Focal Cerebral Ischemia-Reperfusion Injury by Inhibiting NLRP3 Inflammasome Activation and Regulating Microglia/Macrophage Polarization via TLR4/NF-κB Signaling Pathway.

Authors:  Yingze Ye; Tong Jin; Xu Zhang; Zhi Zeng; Baixin Ye; Jinchen Wang; Yi Zhong; Xiaoxing Xiong; Lijuan Gu
Journal:  Front Cell Neurosci       Date:  2019-12-16       Impact factor: 5.505

Review 6.  Beneficial Effects of Citrus-Derived Polymethoxylated Flavones for Central Nervous System Disorders.

Authors:  Kentaro Matsuzaki; Yasushi Ohizumi
Journal:  Nutrients       Date:  2021-01-04       Impact factor: 5.717

7.  Nobiletin ameliorates cardiac impairment and alleviates cardiac remodeling after acute myocardial infarction in rats via JNK regulation.

Authors:  Zumei Liu; Zhimin Gao; Lihuan Zeng; Zhenye Liang; Dechong Zheng; Xiaoqian Wu
Journal:  Pharmacol Res Perspect       Date:  2021-04

8.  MicroRNA‑214 suppresses propofol‑induced neuroapoptosis through activation of phosphoinositide 3‑kinase/protein kinase B signaling by targeting phosphatase and tensin homolog expression.

Authors:  Xukeng Guo; Minghua Cheng; Weiqi Ke; Yuting Wang; Xuan Ji
Journal:  Int J Mol Med       Date:  2018-08-08       Impact factor: 4.101

Review 9.  Snapshot: Implications for mTOR in Aging-related Ischemia/Reperfusion Injury.

Authors:  Dong Liu; Liqun Xu; Xiaoyan Zhang; Changhong Shi; Shubin Qiao; Zhiqiang Ma; Jiansong Yuan
Journal:  Aging Dis       Date:  2019-02-01       Impact factor: 6.745

10.  Nobiletin alleviates ischemia/reperfusion injury in the kidney by activating PI3K/AKT pathway.

Authors:  Bo Liu; Quanhong Deng; Lei Zhang; Wen Zhu
Journal:  Mol Med Rep       Date:  2020-10-01       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.